HeartBeam, Inc. (BEAT)
NASDAQ: BEAT · Real-Time Price · USD
1.580
-0.080 (-4.82%)
At close: May 21, 2025, 4:00 PM
1.650
+0.070 (4.43%)
After-hours: May 21, 2025, 7:52 PM EDT

Company Description

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting.

The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection.

The company was incorporated in 2015 and is based in Santa Clara, California.

HeartBeam, Inc.
HeartBeam logo
Country United States
Founded 2015
IPO Date Nov 11, 2021
Industry Health Information Services
Sector Healthcare
Employees 21
CEO Robert Eno

Contact Details

Address:
2118 Walsh Avenue, Suite 210
Santa Clara, California 95050
United States
Phone (408) 899-4443
Website heartbeam.com

Stock Details

Ticker Symbol BEAT
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $6.00
CIK Code 0001779372
CUSIP Number 42238H108
ISIN Number US42238H1086
Employer ID 47-4881450
SIC Code 3841

Key Executives

Name Position
Richard M. Ferrari Executive Chairman
Timothy Cruickshank Chief Financial Officer
Kenneth Persen Chief Technology Officer
Richa Gujarati Senior Vice President of Product
Dr. Lance Myers Ph.D. Chief Artificial Intelligence Scientist

Latest SEC Filings

Date Type Title
May 19, 2025 PRE 14A Other preliminary proxy statements
May 13, 2025 10-Q Quarterly Report
May 5, 2025 8-K Current Report
Apr 25, 2025 8-K Current Report
Mar 13, 2025 10-K Annual Report
Feb 26, 2025 8-K Current Report
Feb 18, 2025 8-K Current Report
Feb 14, 2025 424B5 Filing
Jan 8, 2025 FWP Free Writing Prospectus
Dec 23, 2024 424B5 Filing